首页|炎琥宁与更昔洛韦治疗病毒性肺炎的成本-效果分析

炎琥宁与更昔洛韦治疗病毒性肺炎的成本-效果分析

扫码查看
目的:探讨应用炎琥宁和更昔洛韦治疗病毒性肺炎的疗效、不良反应及成本-效果比差异。方法采用回顾性分析,选择2012年1月~2014年1月病毒性肺炎患者112例,将以上患者随机分为两组,炎琥宁组和更昔洛韦组。确定两组患者成本,分析两组患者成本效果。结果两组患者总有效率比较,差异无统计学意义(P>0.05);获得1个单位效果情况下,更昔洛韦组所用成本小于炎琥宁组,差异有统计学意义(P<0.05)。结论更昔洛韦组静滴方案临床效果显著且成本较小。
cost-effectiveness of two different treatments for the viral pneumonia with ganciclovir or potassium sodium dehydroandrograpolide succinate for injection
Objective To investigate the cost-effectiveness of two different treatments for the viral pneumonia with ganciclovir or potassium sodium dehydroandrograpolide succinate for injection. Methods Chose 112 patients with viral pneumonia from January 2012 to January 2014,and divided them into two groups,potassium sodium dehydroandrograpolide succinate group and ganciclovir group. Results The total effective rates in two groups were not different(P>0.05);after 1 unit of effect,the cost in the ganciclovir group was smal er than that in the potassium sodium dehydroandrograpolide succinate group. Conclusion The clinical effect of ganciclovir is remarkable,and the cost is smal .

viral pneumoniaCost effectivenessganciclovirpotassium sodium dehydroandrograpolide succinate

赵足华、毛永莲

展开 >

湖南省娄底市第一人民医院药剂科 湖南娄底 417000

病毒性肺炎 成本效果 更昔洛韦 炎琥宁

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(7)
  • 2
  • 1